Latest News

Cousins Properties recently received an upgrade to a Zacks Rank #2 (Buy), after analysts steadily raised their earnings estimates over recent months. This shift in analyst sentiment points to improving expectations for the REIT’s underlying business performance and earnings outlook. Next, we’ll explore how the Zacks rating upgrade and rising earnings estimates may reshape Cousins Properties’ broader investment narrative. Outshine the giants: these 27 early-stage AI stocks could fund your...

We feel now is a pretty good time to analyse Money Forward, Inc.'s ( TSE:3994 ) business as it appears the company may...

Fourth Quarter Beat and Insider Buying Put Blue Bird in Focus Blue Bird (BLBD) just delivered a stronger than expected fiscal fourth quarter, with earnings and revenue topping forecasts, followed quickly by an insider share purchase that underscores management’s confidence. See our latest analysis for Blue Bird. The upbeat quarter and insider buying come after a choppy few months, with a roughly flat 1 month share price return. However, the year to date share price return of about 31 percent...

Wondering whether Textron is still a smart buy at today’s price, or if most of the upside is already baked in? This breakdown will help you decide with a cool head. The stock has quietly climbed 1.8% over the last week and 2.3% over the past month, adding to a 10.7% gain year to date and a strong 75.5% over five years, which naturally raises the question of how much value is left on the table. Recent news has focused on Textron’s growing defense and aviation footprint, from expanding...

If you are wondering whether CVS Health is still a bargain after its big comeback, you are not alone. This stock has quietly turned into one of the more interesting value stories in healthcare. After a choppy few years, CVS is up 76.9% year to date and 47.9% over the last 12 months, even though the last month was slightly negative at -0.9% and the last week only inched ahead by 0.8%. Part of this renewed interest comes from CVS leaning harder into its integrated healthcare model, combining...

The last three months have been tough on PharmaResearch Co., Ltd. ( KOSDAQ:214450 ) shareholders, who have seen the...

If you are wondering whether F5 at around $257 a share is still worth considering after its big run, or if you have missed the boat, this is a good place to unpack what the current price implies. Over the last week the stock is up 8.2%, adding to a 5.0% gain over 30 days and a 66.9% rise over three years, even though the 1 year return is only 0.9% and the move year to date is 2.5%. That uneven performance has played out alongside a steady sequence of product and strategy updates, from F5...

Lumen Technologies (LUMN) just gave investors a lot to digest, pairing a fresh cybersecurity launch for AWS customers with a pending handoff in its top technology role. Both moves point straight at its cloud security ambitions. See our latest analysis for Lumen Technologies. The leadership shuffle and new AWS security product land as Lumen’s share price sits at $8.37, with a punchy 90 day share price return of 48.67 percent and a 3 year total shareholder return of 50.54 percent, suggesting...

If you are wondering whether Flex is still attractive after such a huge run, or if you may be late to the party, this breakdown will help you assess whether the current price still makes sense. The stock has surged 17.6% over the last week, is up 7.8% in the past month, and has risen 74.9% year to date, with a 78.1% gain over the last year and 301.1% over three years, which has clearly changed how the market views its potential. Recently, investors have been reacting to Flex’s role in...

Wondering if Snowflake is still worth buying after its run up and recent wobble, or if the smart money has already moved on? You are not alone, and that is exactly what we are going to unpack here. Despite a strong longer term picture with the stock up 43.0% year to date and 31.3% over the last year, the recent pullback of 13.2% over 7 days and 14.3% over 30 days has reset expectations and opened up fresh questions about risk and reward. Those swings have come as investors digest a wave of...

It might be of some concern to shareholders to see the SITC International Holdings Company Limited ( HKG:1308 ) share...

Waste Management (WM) has quietly outperformed many defensive names this year, and with the stock recently pulling back from its highs, investors are asking whether this is a healthy pause or an early warning sign. See our latest analysis for Waste Management. At around $209.31 per share, WM has given investors a modest 4.37 percent year to date share price return. A 93.91 percent total shareholder return over five years suggests the recent pullback looks more like cooling momentum than a...

Progyny (PGNY) has quietly climbed about 10% over the past month and roughly 57% over the past year, prompting a closer look at what is driving sentiment around this fertility benefits specialist. See our latest analysis for Progyny. That recent 10.4% 1 month share price return, on top of a strong year to date share price gain, suggests momentum is rebuilding as investors refocus on Progyny’s growth and reassess past worries reflected in its weaker multi year total shareholder returns. If...

Wondering if Biogen is quietly becoming a bargain again, or if the market still has it priced like yesterday's story? This breakdown will walk you through what the numbers are really saying about its value. After a tough few years, the stock has started to show signs of life, with shares up around 1.5% over the last week, 16.0% over the past month, and 20.3% year to date, even though the 3-year and 5-year returns remain negative. Recent moves have been driven by shifting sentiment around...

Key Insights Institutions' substantial holdings in SG HoldingsLtd implies that they have significant influence over the...

Hapag-Lloyd (XTRA:HLAG) has been quietly grinding higher, with the stock up around 1% today and roughly 4% over the past week, even as year to date performance remains negative. See our latest analysis for Hapag-Lloyd. That recent pop in the share price looks more like the start of stabilising momentum than a full trend change. A modest 3 month share price return contrasts sharply with the weak year to date share price return and still solid 5 year total shareholder return. If Hapag-Lloyd has...

If you are wondering whether Primo Brands at around $15.77 is a bargain or a value trap, you are not alone. This stock has all the ingredients of a classic valuation puzzle. Over the last month the share price has climbed roughly 9.1%, even though it is still down 49.1% year to date and 47.7% over the last year. This suggests that sentiment is shifting, but the long-term scars are still visible. That recent rebound has come as investors digested a series of strategic updates, including...

If you have ever wondered whether Costco Wholesale is still a smart buy at around $887 a share, you are not alone. Plenty of investors are trying to figure out if the current price still leaves room for value. The stock has slipped recently, down about 2.7% over the last week, 3.8% over the past month, and 2.5% year to date, yet it still sits on gains of 89.6% over 3 years and 150.5% over 5 years, which keeps the long term story in focus. Much of the recent share price action has been driven...

Wondering if Crown Holdings is actually good value at around $94 a share, or if the easy money has already been made, you are not alone. Despite being up 16.0% year to date and 8.5% over the last year, the stock has cooled recently with a 4.0% dip over the past week and a 3.7% slide across the last month. Those moves have come as investors reassess packaging stocks more broadly, with Crown often in the conversation thanks to its global footprint and exposure to consumer staples. At the same...

Advanced Micro Devices (AMD) stock is back in the spotlight after President Donald Trump moved to let US chipmakers resume selling advanced AI processors to approved customers in China, subject to new oversight and a 25% fee. See our latest analysis for Advanced Micro Devices. The policy shift arrives while AMD is already riding a powerful AI wave, with a 90 day share price return of 38.91% and a 1 year total shareholder return of 73.49%, signaling momentum that investors clearly still buy...

In recent days, VanEck’s Matthew Sigel highlighted that MARA Holdings’ US$3.30 billion in convertible debt and structurally high short interest mean its valuation is heavily shaped by its balance sheet rather than simple bitcoin exposure. At the same time, a very large 43,033 BTC transfer to Jack Mallers’ Twenty One ahead of its NYSE listing has put fresh attention on where MARA sits among the largest corporate bitcoin holders and how its financing choices influence its risk...

With its stock down 17% over the past three months, it is easy to disregard Ajinomoto (TSE:2802). However, stock prices...

If you are wondering whether JD.com is quietly turning into a value opportunity after years of pain, you are not alone. This is exactly the question we are going to unpack. Despite a tough run, with the share price down about 1.2% over the last week, 6.6% over the past month, and still roughly 22.8% lower over the last year, the stock is starting to look more interesting to value focused investors. Recent headlines have focused on JD.com sharpening its focus on core e commerce, doubling down...

Wondering if Novo Nordisk is still worth buying after all the excitement around weight loss and diabetes treatments, or if the best days are already priced in. The stock has been choppy recently, down 2.6% over the last week but still up 2.7% over the past month, and longer term it has swung from a 53.8% gain over five years to a steep 60.7% drop in the last year, which says a lot about shifting expectations and risk appetite. Those moves sit against a backdrop of ongoing buzz around its GLP...